Company Filing History:
Years Active: 2002-2005
Title: The Innovative Contributions of Brian Crowe
Introduction
Brian Crowe is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of vaccine development, particularly in the prevention and treatment of Lyme disease. With a total of 2 patents to his name, Crowe's work is recognized for its innovative approaches and scientific rigor.
Latest Patents
Crowe's latest patents include an immunogenic formulation of OspC antigen vaccines for the prevention and treatment of Lyme disease. This patent outlines a novel approach to Borrelia vaccine formulation, taking into account serological, genotypic, and epidemiological information. The method groups OspC proteins from different strains together, ensuring that the selected OspC antigens constitute a representative sample. This strategy aims to provide the greatest cross-protectivity with the fewest number of antigens.
Career Highlights
Brian Crowe is currently employed at Baxter Vaccine AG, where he continues to advance his research in vaccine development. His work has been instrumental in shaping modern approaches to immunization against Lyme disease.
Collaborations
Crowe collaborates with esteemed colleagues such as Ian Livey and Friedrich Dorner, contributing to a dynamic research environment that fosters innovation and scientific discovery.
Conclusion
Brian Crowe's contributions to vaccine development highlight the importance of innovative thinking in addressing public health challenges. His patents reflect a commitment to improving health outcomes through scientific advancement.